Entrepreneurship in Peace Operations

Journal of Civic Society," 6(01), (2010), pp. 1-21.A central question guides this article: To what extent can entrepreneurship be a force for change and transformation in war-torn areas? To address the question, this article introduces the topic of social entrepreneurship and illustrates how social entrepreneurs are serving as change agents in rebuilding and reconstructing areas devastated by conflict. The social enterprise of Kiva, the brainchild of social entrepreneurs Matthew Flannery and Jessica Jackley, provides an example. It is notable for its innovative idea—a Web-based, internet-facilitated micro-loan process that attracts individual investors worldwide in support of business entrepreneurs in the developing world. As a counter example to top-down, mandate-driven, organization-centric intervention strategies that many organizations pursue in peace operations, Kiva’s enduring legacy may very well be its bottom-up, entrepreneur-driven, network-centric model of change. Its most salient features are: a supply chain that ‘contractually’ connects all the partners in the loan process to minimize coordination problems and ensure that each step in the workflow sequentially adds value; processes and systems that guarantee work is transparent, efficient and accountable; a model of learning that enables global and local partners to co-create a complex, worldwide community-based learning system in support of entrepreneurship; and a rich network of social relations built from face-to-face and online interactions to help generate social capital needed for development

Gut microbiome, liver immunology, and liver diseases

The gut microbiota is a complex and plastic consortium of microorganisms that are intricately connected with human physiology. The liver is a central immunological organ that is particularly enriched in innate immune cells and constantly exposed to circulating nutrients and endotoxins derived from the gut microbiota. The delicate interaction between the gut and liver prevents accidental immune activation against otherwise harmless antigens. Work on the interplay between the gut microbiota and liver has assisted in understanding the pathophysiology of various liver diseases. Of immense importance is the step from high-throughput sequencing (correlation) to mechanistic studies (causality) and therapeutic intervention. Here, we review the gut microbiota, liver immunology, and the interaction between the gut and liver. In addition, the impairment in the gut–liver axis found in various liver diseases is reviewed here, with an emphasis on alcohol-associated liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), and autoimmune liver disease (AILD). On the basis of growing evidence from these preclinical studies, we propose that the gut–liver axis paves the way for targeted therapeutic modalities for liver diseases